Study Stopped
during anticipated study duration trial power was not attained.
PENTACON Trial: Partial ENdothelial Trepanation in Addition to Anterior Lamellar Keratoplasty in keratoCONus
PENTACON
Pentacon Trial: Partial ENdothelial Trepanation in Addition to Anterior Lamellar Keratoplasty in keratoCONus. A Prospective Multicenter Randomized Controlled Trial
1 other identifier
interventional
14
1 country
5
Brief Summary
Rationale: Keratoconus is a progressive, non-inflammatory corneal disease in which irregular refractive properties of the cornea result in loss of visual acuity. Treatment is aimed at improving vision, principally using (rigid) contact lenses. With progression of the disease non-correctable refractive abnormalities and/or corneal scars arise. For these advanced stages of keratoconus, a corneal transplant is the only treatment modality. New surgical grafting modalities have been developed to create partial thickness grafts, according to the location of corneal pathology. For keratoconus, transplanting only the anterior corneal lamellae lowers long-term graft rejection rates. We utilize a method to enhance the safety of the grafting procedure while better visual outcomes are expected. Objective: To investigate the additional value of partial endothelial trepanation (PET) in an anterior lamellar keratoplasty (ALKP) procedure in terms of efficacy and safety in patients with keratoconus. Study design: A randomized controlled interventional trial Study population: Patients over 18 years old with keratoconus in whom contact lens correction is unsuccessful and who are not suitable for corneal crosslinking. Intervention: Patients will be randomly assigned to corneal grafting techniques; partial endothelial trepanation in addition to an anterior lamellar keratoplasty (i.e. the PET group) or a regular ALKP procedure. Study outcomes: Risk of per-operative perforation. Secondary, factors contributing to treatment safety and efficacy. Nature and extent of the burden and risks associated with participation, benefit and group relatedness: There is no extra burden or risk associated with participation in this study. All measurements are part of normal clinical practice. Adequate experience is available with both surgical techniques. Study participation has no effect on donor selection. If partial endothelial trepanation (PET) is associated with lower complication rates and better visual outcomes, this might be beneficial in terms of morbidity.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Mar 2011
Longer than P75 for not_applicable
5 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
June 14, 2010
CompletedFirst Posted
Study publicly available on registry
June 17, 2010
CompletedStudy Start
First participant enrolled
March 1, 2011
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 1, 2015
CompletedStudy Completion
Last participant's last visit for all outcomes
May 1, 2015
CompletedDecember 3, 2015
December 1, 2015
4.2 years
June 14, 2010
December 2, 2015
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Peroperative corneal perforation
Peroperative corneal perforation is the biggest drawback of currently utilized grafting procedures (ALKP, 20-30%). Our new technique is believed to be safer, by reducing the number of corneal perforations during surgery. Corneal perforation necessitates converting the procedure to a full-thickness graft with a less favourable long term rejection profile.
During Surgery. From start to closure of surgical procedure approx. 2h
Secondary Outcomes (6)
Best corrected visual acuity one year post op
One year post-op
Manifest refraction one year post op
One year post-op
Contact lens use (soft/rigid/scleral) or spectacle use
one year post-op
Self-rated improvement questionnaire
One year post-op
Corneal endothelial function one year post op
One year post-op
- +1 more secondary outcomes
Study Arms (2)
PET
EXPERIMENTALPartial endothelial trepanation in addition to anterior lamellar keratoplasty. The endothelium en Descemet are paracentrally and circular loosened, but some tissue bridges are left in place. This 'island' is able to mould to the healthy donor curvature.
DALK
ACTIVE COMPARATORConventional DALK grafting procedure where the Big Bubble technique is used according to Anwar et al.
Interventions
Eligibility Criteria
You may qualify if:
- age equal or above 18 years
- keratoconus as defined and classified by
- presence of corneal thinning and protrusion on slit-lamp examination
- topographic criteria according to KISA% index (\>100%)
- mean corneal curvature map
- decreased best corrected visual acuity due to corneal scarring or contact lens intolerance
You may not qualify if:
- prior corneal surgery, cross linking, refractive surgery or other treatment modalities
- (localized) corneal thickness \< 200 µm
- associated corneal endothelial disease on specular microscopy as defined by:
- \<1500 endothelial cells per mm2
- polymegathism \> 0.3
- pleomorphism \< 0.6 (all are measurements of endothelial dysfunction)
- gross ophthalmic pathology surpassing keratoconus as cause of decreased visual acuity
- keratoconus-like disease (keratoglobus, pellucid marginal degeneration)
- associated corneal anomalies (microcornea, macrocornea, buphthalmos, Peters syndrome, ICE-syndrome etc.)
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- UMC Utrechtlead
- Dr. F.P. Fischer-stichting, Utrecht, The Netherlandscollaborator
Study Sites (5)
Amphia Ziekenhuis
Breda, 4819 EV, Netherlands
Westfries Gasthuis
Hoorn, 1620 AR, Netherlands
UMCN St. Radboud
Nijmegen, 6500HB, Netherlands
Rotterdam Eye Hospital
Rotterdam, 3000 LM, Netherlands
University Medical Center Utrecht
Utrecht, 3508 GA, Netherlands
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Allegonda Van der Lelij, MD PhD
UMC Utrecht
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Ophthalmologist
Study Record Dates
First Submitted
June 14, 2010
First Posted
June 17, 2010
Study Start
March 1, 2011
Primary Completion
May 1, 2015
Study Completion
May 1, 2015
Last Updated
December 3, 2015
Record last verified: 2015-12